Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AMGN · against 1,372 other Healthcare companies
Ranked #1,254 of 1,373 · scores higher than 9% of peers · safety percentile 9
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 0–9, including AMGN · Click a bar to see the companies
Mainly because of its debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | AMGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 4.90× | 0.24× | 2% | 33% | |
| BetaLower is better · 1,320 reported | 0.41 | 0.53 | 59% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.37× | 2.62× | 22% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,250 | 1.1B EUR (≈$1.2B) | 9 | 44 | |
| 1,251 | 513M USD | 9 | 31 | |
| 1,252 | 390.5B IDR (≈$24M) | 9 | 8 | |
| 1,253 | 4.7B USD | 9 | 42 | |
| 1,254 | 249.4B USD | 9 | 55 | |
| 1,255 | 116.5B USD | 9 | 57 | |
| 1,256 | 532M USD | 9 | 34 | |
| 1,257 | 363M AUD (≈$240M) | 8 | 31 | |
| 1,258 | 646M USD | 8 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score